Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Lachance S, Bourguignon A, Boisjoly JA, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Veilleux O, Zehr J, Chagnon M, Roy J. Lachance S, et al. Among authors: mollica l. Transplant Cell Ther. 2023 Jan;29(1):34.e1-34.e7. doi: 10.1016/j.jtct.2022.10.003. Epub 2022 Oct 12. Transplant Cell Ther. 2023. PMID: 36243319 Free article.
Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S. Lemieux C, et al. Among authors: mollica l. Biol Blood Marrow Transplant. 2020 Jan;26(1):157-161. doi: 10.1016/j.bbmt.2019.09.007. Epub 2019 Sep 12. Biol Blood Marrow Transplant. 2020. PMID: 31521818 Free article. Clinical Trial.
Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy.
Liu J, Stewart D, Fontaine A, Peters A, Fleury I, Mollica L, Prica A, Buckstein R, Sehn L, Jiang A, Kuruvilla J, Villa D. Liu J, et al. Among authors: mollica l. Leuk Lymphoma. 2020 Oct;61(10):2492-2496. doi: 10.1080/10428194.2020.1772472. Epub 2020 Jun 10. Leuk Lymphoma. 2020. PMID: 32519592 No abstract available.
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Veilleux O, Claveau JS, Alaoui H, Roy J, Ahmad I, Delisle JS, Kiss T, Bambace NM, Bernard L, Cohen S, Sauvageau G, Fleury I, Mollica L, Roy DC, Serroukh Y, Lachance S. Veilleux O, et al. Among authors: mollica l. Transplant Cell Ther. 2022 Mar;28(3):145-151. doi: 10.1016/j.jtct.2021.12.005. Epub 2021 Dec 23. Transplant Cell Ther. 2022. PMID: 34954149 Free article.
94 results